Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 36Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 11Neoplasms 9Neoplasm Metastasis 9Sarcoma 4Lung Neoplasms 4Esophageal Neoplasms 4Adenocarcinoma 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Melanoma 3Breast Neoplasms, Male 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Diseases 2Metastatic Pancreatic Adenocarcinoma 2Carcinoma 2Advanced Solid Tumor 2Tongue Neoplasms 1Thymus Neoplasms 1Solid Cancer 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic cancer, adult 1Ovarian Neoplasms 1

Interventions

pembrolizumab 2Cisplatin 2pralsetinib 1ficlatuzumab 1Taxes 1Pemetrexed 1Paclitaxel 1Irinotecan 1Gemcitabine 1Gefitinib 1Drug Therapy 1Capecitabine 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neoplasms, Glandular and Epithelial × Albumin-Bound Paclitaxel × Clear all
NCT03535727 2024-12-31

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
48 enrolled 24 charts
Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡